BioCentury
ARTICLE | Financial News

Aisling closes $550 million fund

January 5, 2006 1:31 AM UTC

Aisling Capital closed its Aisling Capital II fund at $550 million. The firm, which was spun out of Perseus-Soros Management, said it will invest primarily in companies that are developing biopharmace...